1 / 43

Ischemic Heart Disease

Ischemic Heart Disease. Hisham Alkhalidi. Ischemic Heart Disease. A group of related syndromes resulting from myocardial ischemia. Ischemic Heart Disease. The vast majority of ischemic heart disease is due to coronary artery atherosclerosis Less frequent contributions of: vasospasm

binah
Télécharger la présentation

Ischemic Heart Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ischemic Heart Disease HishamAlkhalidi

  2. Ischemic Heart Disease A group of related syndromes resulting from myocardial ischemia

  3. Ischemic Heart Disease • The vast majority of ischemic heart disease is due to coronary artery atherosclerosis • Less frequent contributions of: • vasospasm • vasculitis • Is it exactly the same as coronary artery disease (CAD)? • Frequently yes

  4. Ischemic Heart Disease Angina pectoris • Chestpain: • Can radiate down the left arm or to the left jaw (referred pain) • Due to inadequate perfusion • Duration and severity is not sufficient for infarction

  5. Ischemic Heart Disease Stable angina • Occurring reliably after certain levels of exertion • Typically due to atherosclerotic disease with ≥75% (critical stenosis) fixed chronic stable stenosis

  6. Ischemic Heart Disease Unstable angina • Unstable (occurring with progressively less exertion or even at rest) • Results from a small fissure or rupture of atherosclerotic plaque triggering: • Platelet aggregation • Vasoconstriction • Formation of a mural thrombus that may not be occlusive • Usually proceed MI

  7. Ischemic Heart Disease Variant angina • Vessel spasm or Prinzmetal angina • Without fixed atherosclerotic disease • The etiology is not clear • Responds promptly to vasodilators, such as nitroglycerin and calcium channel blockers

  8. Ischemic Heart Disease Myocardial infarction • The severity or duration of ischemia is enough to cause cardiac muscle death • Typically results from acute thromboses that follow plaque disruption

  9. Ischemic Heart Disease MI types • Transmural • Full thickness (>50% of the wall) • Subendocardial • Inner 1/3 of myocardium • Two mechanisms: • Fixed atherosclerosis but with increased demand, vasospasm or hypotension OR • Evolving transmural with relieve of the obstruction (often multifocal)

  10. Ischemic Heart Disease MI, common locations • In Right dominant coronary artery heart (90% of population): • 2 cm proximal LAD (up to 50%) • anterior left ventricle • anterior septum • apex circumferentially • Left circumflex ( up to 20%) • infarct involves lateral left ventricle except the apex • 1st and last thirds of RCA (up to 40%) • posterior left ventricle • posterior septum • right ventricular free wall, sometime

  11. Ischemic Heart Disease Ischemia to myocardium rapidly (minutes) leads to loss of function and causes necrosis after 20 to 40 minutes

  12. Ischemic Heart Disease Clinical picture of MI • Severe, crushing substernal chest pain or discomfort that can radiate to the neck, jaw, epigastrium, or left arm • Diaphoresis • Nausea • Dyspnea • Can be silent (DM, old age)

  13. Ischemic Heart Disease ECG • Changes such as: • Q waves (indicating transmural infarcts) • ST-segment abnormalities • T-wave inversion • Arrhythmias

  14. Ischemic Heart Disease Laboratory evaluation • Cardiac troponins T and I (TnT, TnI) • Creatine kinase (CK, and more specifically the myocardial-specific isoform, CK-MB) • Lactate dehydrogenase • Myoglobin Troponins and CK-MB have high specificity and sensitivity for myocardial damage

  15. Ischemic Heart Disease Laboratory evaluation • TnI and TnT are not normally detectable in the circulation • After acute MI both troponins: • Become detectable after 2 to 4 hours • Peak at 48 hours • Their levels remain elevated for 7 to 10 days

  16. Ischemic Heart Disease Laboratory evaluation • CK-MB is the second best marker • CK-MB activity: • Begins to rise within 2 to 4 hours of MI • Peaks at 24 to 48 hours • Returns to normal within approximately 72 hours

  17. Ischemic Heart Disease Complications of MI • At least 80% will suffer: • Cardiogenic shock (>40% infarct of LV) • Congestive heart failureCHF • Arrhythmia • Rupture of ventricle, free wall, septum, or papillary muscle • Aneurysm formation, • Mural thrombus, potentially source of emboli • Pericarditis

  18. Ischemic Heart Disease MI death and complications rates • 25% die, presumably due to arrythmia • 10% of the rest will die within a month • 80-90% will develop complications • Overall 30% die in the 1st year and then 10% per year

  19. Chronic ischemic heart disease • Progressive heart failure due to ischemic injury, either from: • prior infarction(s) (most common) • chronic low-grade ischemia

  20. Ischemic Heart Disease Sudden cardiac death • Unexpected death from cardiac causes either without symptoms or within 1 to 24 hours of symptom onset (different authors use different time points) • Results from a fatal arrhythmia, most commonly in patients with severe coronary artery disease

  21. Ischemic Heart Disease Acute coronary syndrome • is applied to three catastrophic manifestations of IHD: • Unstable angina • Acute MI • Sudden cardiac death

More Related